Role of circulating karyocytes in the initiation and progression of atherosclerosis

Helena Chon1, Marianne C Verhaar, Hein A Koomans

  • 1Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands.

Insights

Cardiovascular disease risk factors make leukocytes hypersensitive to normal stimuli, altering gene transcription and promoting inflammation. Monitoring leukocyte gene expression may improve atherosclerosis understanding and treatment guidance.

Area of Science:

  • Cardiovascular biology
  • Cellular and molecular medicine
  • Immunology

Background:

  • Cardiovascular disease (CVD) prediction remains challenging, with research focusing on vessel wall cells and blood biochemistry.
  • Alterations in circulating blood cells, particularly leukocytes, have been under-investigated despite their role in CVD.
  • Existing research has not fully elucidated how cardiovascular risk factors impact leukocyte function at the molecular level.

Purpose of the Study:

  • To investigate how cardiovascular risk factors induce redox-dependent changes in leukocyte gene transcription.
  • To explore the hypothesis that risk factors render leukocytes hypersensitive to physiological stimuli.
  • To establish leukocyte gene expression signatures as potential biomarkers for atherosclerosis progression and treatment.

Main Methods:

  • Analysis of redox-dependent changes in leukocyte gene transcription induced by risk factors and physiological stimuli.
  • Investigating the role of pro-oxidative states and redox-sensitive transcription factors in leukocyte activation.
  • Examining gene expression signatures in leukocytes, specifically monocytes, from individuals with cardiovascular risk factors.

Main Results:

  • Cardiovascular risk factors, combined with normal stimuli, induce redox-dependent alterations in leukocyte gene transcription.
  • These alterations lead to pathophysiological responses including inflammation, adhesion, and migration.
  • Leukocytes become hypersensitive to normal physiological stimuli in the presence of risk factors, promoting a pro-oxidative state.

Conclusions:

  • Monitoring leukocyte gene expression signatures can enhance understanding of leukocyte and monocyte function in CVD.
  • Leukocyte transcriptomes may serve as tools to assess atherosclerotic disease aggressiveness.
  • Gene expression profiling of leukocytes could guide therapeutic strategies for patients with atherosclerosis risk factors.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Inflammation01:38

Inflammation

Overview
Karyotyping01:17

Karyotyping

Describing the number and physical features of chromosomes can reveal abnormalities that underlie genetic diseases. This description is facilitated by special staining techniques that produce a particular banding pattern on each chromosome. State-of-the-art techniques make this approach even more powerful, enabling the detection of individual genes that cause disease.A Simple Chromosome Staining Technique Provides Valuable Scientific InsightSome genetic diseases can be detected by looking at...